Evidence map›Paper›PMID 33942160›Full record

ArticleJournal of neurology2021

A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis.

Serena Ruggieri, Maria Petracca, Laura De Giglio, Francesca De Luca, Costanza Giannì, Flavia Gurreri, Nikolaos Petsas, Silvia Tommasin, Carlo Pozzilli, Patrizia Pantano

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Charting Cervical Spinal Cord Morphometry Across the Lifespan.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Serena RuggieriDepartment of Human Neurosciences, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0001-5287-3290
Maria PetraccaDepartment of Human Neurosciences, Sapienza University, Rome, Italy. maria@petraccas.it.ORCID http://orcid.org/0000-0001-9429-2769
Laura De GiglioDepartment of Human Neurosciences, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0001-9018-7320
Francesca De LucaPhD Program in Behavioral Neuroscience, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0001-7128-9225
Costanza GiannìDepartment of Radiology, IRCCS NEUROMED, Pozzilli, Italy.ORCID http://orcid.org/0000-0002-4018-169X
Flavia GurreriMS Center, Sant'Andrea Hospital, Rome, Italy.ORCID http://orcid.org/0000-0003-1623-5501
Nikolaos PetsasDepartment of Radiology, IRCCS NEUROMED, Pozzilli, Italy.ORCID http://orcid.org/0000-0001-7150-9697
Silvia TommasinDepartment of Human Neurosciences, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0001-9088-7968
Carlo PozzilliDepartment of Human Neurosciences, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0002-6360-4798
Patrizia PantanoDepartment of Human Neurosciences, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0001-9659-8294
Istituto Neurologico Mediterraneo · ITCTO Andrea Alesini · ITSapienza University of Rome · ITFondazione Santa Lucia · ITOspedale San Filippo Neri · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investigated the impact of different patterns of brain and spinal cord atrophy on disability worsening in MS. We acquired clinical and MRI data from 90 patients with relapsing-remitting MS and 24 healthy controls (HC). Clinical progression at follow-up (mean 3.7 years) was defined according to the Expanded Disability Status Scale-Plus. Brain and spinal cord volumes were computed on MRI brain scans. After normalizing each participants' brain and spine volume to the mean of the HC, z-score cut-offs were applied to separate pathologically atrophic from normal brain and spine volumes (accepting a 2.5% error probability). Accordingly, MS patients were classified into four groups (Group I: no brain or spinal cord atrophy N = 40, Group II: brain atrophy/no spinal cord atrophy N = 11, Group III: no brain atrophy/ spinal cord atrophy N = 32, Group IV: both brain and spinal cord atrophy N = 7). All patients' groups showed significantly lower brain volume than HC (p < 0.0001). Group III and IV showed lower spine volume than HC (p < 0.0001 for both). Higher brain lesion load was identified in Group II (p = 0.049) and Group IV (p = 0.023) vs Group I, and in Group IV (p = 0.048) vs Group III. Spinal cord atrophy (OR = 3.75, p = 0.018) and brain + spinal cord atrophy (OR = 5.71, p = 0.046) were significant predictors of disability progression. The presence of concomitant brain and spinal cord atrophy is the strongest correlate of progression over time. Isolated spinal cord atrophy exerts a similar effect, confirming the leading role of spinal cord atrophy in the determination of motor disability.

Indexed as

Motor DisordersMultiple SclerosisPersons with DisabilitiesAtrophyBrainDisability EvaluationHumansBrain atrophyDisability worseningMultiple sclerosisSpinal cord atrophy

Identifiers

PMID33942160
PMCPMC8563557
OpenAlexW3158717926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.